A new analysis found that nearly 700 drugs approved for use in the United States depend on chemicals solely produced in China ...

The U.S. Food and Drug Administration has awarded the National Institute for Pharmaceutical Technology and Education a grant worth up to $35 million over the next five years to improve drug ...

For years, pharmaceutical scientists have sought to enhance bioavailability by transforming drugs from their crystalline state into more soluble, amorphous forms. Traditional methods like spray drying ...

Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and ...

When Adam Kovalčík flew to Ohio for an international science competition, he did not expect to come home with $100,000. The 19-year-old from Dulovce, Slovakia won that sum on Friday, though, because ...

As the conference approaches, scientists are reviewing new technologies that enhance manufacturing process control, product ...

It could be years before a cell therapy from Nkarta reaches autoimmune disease patients in the market, but CEO Paul Hastings still thinks about the impact of pharmaceutical tariffs here and now. With ...

The FDA named the first nine products to undergo a new expedited review process that takes 1 to 2 months, the agency ...

The FDA in June launched the new Commissioner's National Priority Voucher pilot program under which it could issue vouchers ...

Adam Kovalčík, age 19, innovated a cheaper, faster way to produce an antiviral drug. Galidesivir targets RNA viruses like COVID-19, Ebola, and Zika but hasn't completed clinical trials. Kovalčík won a ...